Navigation Links
PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
Date:10/5/2009

http://www.hstvchannel.com/ThreatMatrix/Deadly_Pathogen_Anthrax.html

Homeland Security Television Channel

The Homeland Security Television Channel (HSTV) is the world's first online, on-demand television network dedicated to homeland security and global development. HSTV is a 24/7 interactive television channel dedicated to producing broadcast-quality video programs on all aspects of homeland security and the role of global development in fighting terrorism. http://www.hstvchannel.com

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit www.PharmAthene.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not his
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
2. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
3. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
4. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
5. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
6. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
7. PharmAthene Reports First Quarter 2009 Financial and Operational Results
8. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
9. PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
10. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
11. PharmAthene Announces $5.5 Million Public Equity Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Albany Molecular Research Inc. (NASDAQ: AMRI ... AMRI,s President and Chief Executive Officer, will present at ... Conference on Wednesday, May 13, 2015 at 4:20 p.m. ... presentation can be accessed at AMRI,s Investor Relations web ... will be archived for 90 days following the live ...
(Date:4/30/2015)... April 30, 2015  Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens, ... first quarter of 2015 on May 7, 2015 after ... Bioscience will also host a conference call at 4:30 ... its first quarter financial results. During the conference call, ...
(Date:4/30/2015)... (PRWEB) April 30, 2015 Nitto ... today announces its increased capacity and production capability ... increased client variety and service fulfillment continues to ... improve process throughput capacities. , ... newly installed downstream process equipment at its Milford, ...
(Date:4/30/2015)... , April 30, 2015  The Paul G. Allen ... Investigator (ADI) grants to six groups of researchers with ... challenging roadblocks in neuroscience: growing mature human brain cells ... total of $7.5 million over three years.  ... their research is especially significant because the field of ...
Breaking Biology Technology:AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 3The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 5
... Universite de Montreal and Validapro Biosciences Inc. have signed an ... standards of the biotherapeutic manufacturing unit located at the Faculty ... veterinary clinical use. , ... Laval, ...
... 19 , - Completed ... Opsona Therapeutics, a biotechnology company focused ... diseases, today,announced that Roche Venture Fund and Enterprise Ireland ... financing announced in February,this year, bringing the total round ...
... for Mometasone Furoate/Formoterol Combination for Asthma and ... (NYSE: SGP ) today announced ... for the development and commercialization of fixed-dose ... and chronic obstructive pulmonary disease (COPD). ...
Cached Biology Technology:Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 2Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 4Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 5Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 6Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 7Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 8
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... 11, 2010) Advancement in the treatment of cocaine overdoses ... just two examples of the groundbreaking research that will be ... Biotechnology Conference (NBC). The conference takes place Sunday, May 16 ... in San Francisco, Calif. A Possible ...
... Arts and Sciences has received a $9.5 million grant ... Cluster in Genome Structure and Developmental Patterning in Health ... such areas as genome structure and stability, developmental and ... to organism" research to advance treatment of hereditary diseases, ...
... LA JOLLA, Calif., May 11, 2010 -- Cancer uses ... example is the way tumors express anti-cell death (anti-apoptotic) ... laboratory at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has made ... proteins and make current treatments more effective. In ...
Cached Biology News:Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 3Cancer: Trapping the escape artist 2
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
in vitro Translation, Accessory Products...
Request Info...
... The Zero Blunt ... for Sequencing is designed ... sequencing of blunt-end PCR ... provides 5-minute TOPO Cloning ...
Biology Products: